1887

Abstract

The NS1 protein has been associated with the virulence of influenza A viruses. To evaluate the role of the NS1 protein in pathogenicity of pandemic H5N1 avian influenza and H1N1 2009 influenza viruses, recombinant Newcastle disease viruses (rNDVs) expressing NS1 proteins were generated. Expression of the NS1 proteins resulted in inhibition of host innate immune responses (beta interferon and protein kinase R production). In addition, the NS1 proteins were localized predominantly in the nucleus of virus-infected cells. Consequently, expression of the NS1 protein contributed to an increase in pathogenicity of rNDV in chickens. In particular, mutational analysis of H5N1 NS1 protein indicated that both the RNA-binding and effector domains affect virus pathogenicity synergistically. Our study also demonstrated that expression of H1N1/09 NS1 resulted in enhanced replication of rNDV in human cells, indicating that function of the NS1 proteins can be host-species-specific.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.021766-0
2010-08-01
2019-11-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/91/8/1996.html?itemId=/content/journal/jgv/10.1099/vir.0.021766-0&mimeType=html&fmt=ahah

References

  1. Alexander, D. J. ( 1989; ). Newcastle disease. In A Laboratory Manual for the Isolation and Identification of Avian Pathogens, 3rd edn, pp. 114–120. Edited by H. G. Purchase, L. H. Arp, C. H. Domermuth & J. E. Pearson. Dubuque, IA: American Association of Avian Pathologists, Kendall/Hunt Publishing Company.
  2. Bergmann, M., Garcia-Sastre, A., Carnero, E., Pehamberger, H., Wolff, K., Palese, P. & Muster, T. ( 2000; ). Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol 74, 6203–6206.[CrossRef]
    [Google Scholar]
  3. Donelan, N. R., Basler, C. F. & García-Sastre, A. ( 2003; ). A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol 77, 13257–13266.[CrossRef]
    [Google Scholar]
  4. Ferko, B., Stasakova, J., Romanova, J., Kittel, C., Sereing, S., Katinger, H. & Egorov, A. ( 2004; ). Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J Virol 78, 13037–13045.[CrossRef]
    [Google Scholar]
  5. Geiss, G. K., Salvatore, M., Tumpey, T. M., Carter, V. S., Wang, X., Basler, C. F., Taubenberger, J. K., Bumgarner, R. E., Palese, P. & other authors ( 2002; ). Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A 99, 10736–10741.[CrossRef]
    [Google Scholar]
  6. Greenspan, D., Palese, P. & Krystal, M. ( 1988; ). Two nuclear location signals in the influenza virus NS1 nonstructural protein. J Virol 62, 3020–3026.
    [Google Scholar]
  7. Jackson, D., Hossain, Md. J., Hickman, D., Perez, D. R. & Lamb, R. A. ( 2008; ). A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A 105, 4381–4386.[CrossRef]
    [Google Scholar]
  8. Jiao, P., Tian, G., Li, Y., Deng, G., Jiang, Y., Liu, C., Liu, W., Bu, Z., Kawaoka, Y. & Chen, H. ( 2008; ). A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol 82, 1146–1154.[CrossRef]
    [Google Scholar]
  9. Kochs, G., Garcia-Sastre, A. & Martinez-Sobrido, L. ( 2007; ). Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81, 7011–7021.[CrossRef]
    [Google Scholar]
  10. Krishnamurthy, S., Huang, Z. & Samal, S. K. ( 2000; ). Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 278, 168–182.[CrossRef]
    [Google Scholar]
  11. Lamb, R. A. & Parks, G. D. ( 2007; ). Paramyxoviridae: the viruses and their replication. In Fields Virology, 5th edn, pp. 1449–1496. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
  12. Li, W. X., Li, H., Lu, R., Li, F., Dus, M., Atkinson, P., Brydon, E. W. A., Johnson, K. L., García-Sastre, A. & other authors ( 2004; ). Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc Natl Acad Sci U S A 101, 1350–1355.[CrossRef]
    [Google Scholar]
  13. Li, S., Min, J. Y., Krug, R. M. & Sen, G. C. ( 2006; ). Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349, 13–21.[CrossRef]
    [Google Scholar]
  14. Li, Z., Jiang, Y., Jiao, P., Wang, A., Zhao, F., Tian, G., Wang, X., Yu, K., Bu, Z. & Chen, H. ( 2006; ). The NS1 gene contributes to the virulence of H5N1 avian influenza viruses. J Virol 80, 11115–11123.[CrossRef]
    [Google Scholar]
  15. Melén, K., Kinnunen, L., Fagerlund, R., Ikonen, N., Twu, K. Y., Krug, R. M. & Julkunen, I. ( 2007; ). Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J Virol 81, 5995–6006.[CrossRef]
    [Google Scholar]
  16. Min, J. Y., Li, S., Sen, G. C. & Krug, R. M. ( 2007; ). A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology 363, 236–243.[CrossRef]
    [Google Scholar]
  17. Noah, D. L., Twu, K. Y. & Krug, R. M. ( 2003; ). Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAs. Virology 307, 386–395.[CrossRef]
    [Google Scholar]
  18. Palese, P. & Shaw, M. L. ( 2007; ). Orthomyxoviridae: the viruses and their replication. In Fields Virology, 5th edn, pp. 1647–1689. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
  19. Panda, A., Huang, Z., Elankumaran, S., Rockemann, D. D. & Samal, S. K. ( 2004; ). Role of fusion protein cleavage site in the virulence of Newcastle disease virus. Microb Pathog 36, 1–10.[CrossRef]
    [Google Scholar]
  20. Park, M. S., García-Sastre, A., Cros, J. F., Basler, C. F. & Palese, P. ( 2003; ). Newcastle disease virus V protein is a determinant of host range restriction. J Virol 77, 9522–9532.[CrossRef]
    [Google Scholar]
  21. Poole, E., He, B., Lamb, R. A., Randall, R. E. & Goodbourn, S. ( 2002; ). The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-β. Virology 303, 33–46.[CrossRef]
    [Google Scholar]
  22. Talon, J., Horvath, C. M., Polley, R., Basler, C. F., Muster, T., Palese, P. & García-Sastre, A. ( 2000; ). Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74, 7989–7996.[CrossRef]
    [Google Scholar]
  23. Wang, W., Riedel, K., Lynch, P., Chien, C. Y., Montelione, G. T. & Krug, R. M. ( 1999; ). RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 5, 195–205.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.021766-0
Loading
/content/journal/jgv/10.1099/vir.0.021766-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error